(In thousands)
|
For the Three Months
Ended September 30, |
For the Nine Months
Ended September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Adjusted EBITDA: | ||||||||||||||||
| Net loss | $ | (15,041 | ) | $ | (14,711 | ) | $ | (51,585 | ) | $ | (37,476 | ) | ||||
| Add (deduct): | ||||||||||||||||
| Interest expense, interest and dividend income and other expenses | 139 | 448 | 2,991 | 1,363 | ||||||||||||
| Depreciation and amortization expense(1) | 1,909 | 816 | 5,716 | 2,304 | ||||||||||||
| Income tax benefit | — | — | (559 | ) | — | |||||||||||
| Amortization of lease intangible | 333 | — | 999 | — | ||||||||||||
| Stock-based compensation (2) | 5,113 | 2,266 | 14,048 | 4,747 | ||||||||||||
| Charitable contribution of common stock | 987 | 1,157 | 2,272 | 1,157 | ||||||||||||
| Income from unconsolidated joint venture | (297 | ) | — | (600 | ) | — | ||||||||||
| Acquisition and other (3) | 42 | — | (1,242 | ) | — | |||||||||||
| Impairment of assets | 325 | — | 444 | — | ||||||||||||
| Adjusted EBITDA | $ | (6,490 | ) | $ | (10,024 | ) | $ | (27,516 | ) | $ | (27,905 | ) | ||||
